Envoy Medical, Inc. (NASDAQ:COCH) Short Interest Update

Envoy Medical, Inc. (NASDAQ:COCH) saw a large decline in short interest in November. As of November 30th, there was short interest totalling 287,000 shares, a decline of 19.2% from the November 15th total of 355,300 shares. Based on an average daily volume of 233,600 shares, the short-interest ratio is presently 1.2 days. Currently, 3.7% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Brookline Capital Management began coverage on shares of Envoy Medical in a research report on Monday, October 14th. They set a “buy” rating and a $9.00 price target on the stock. Ascendiant Capital Markets upped their price objective on Envoy Medical from $8.75 to $9.00 and gave the stock a “buy” rating in a report on Friday, December 6th.

Envoy Medical Stock Performance

COCH stock traded down $0.12 during mid-day trading on Friday, hitting $1.96. 55,319 shares of the company were exchanged, compared to its average volume of 192,927. The firm’s 50 day simple moving average is $2.35 and its 200 day simple moving average is $2.54. Envoy Medical has a 1-year low of $1.08 and a 1-year high of $11.46.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.